AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
230.11
-2.24 (-0.96%)
At close: Mar 6, 2026, 4:00 PM EST
229.80
-0.31 (-0.13%)
After-hours: Mar 6, 2026, 7:57 PM EST
AbbVie Market Cap
AbbVie has a market cap or net worth of $406.87 billion as of March 6, 2026. Its market cap has increased by 14.73% in one year.
Market Cap
406.87B
Enterprise Value
470.02B
1-Year Change
14.73%
Ranking
Category
Stock Price
$230.11
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $406.87B, an increase of 633.24%. That is a compound annual growth rate of 16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 406.87B | 0.75% |
| Dec 31, 2025 | 403.83B | 28.60% |
| Dec 31, 2024 | 314.02B | 14.77% |
| Dec 29, 2023 | 273.61B | -4.27% |
| Dec 30, 2022 | 285.80B | 19.40% |
| Dec 31, 2021 | 239.37B | 26.54% |
| Dec 31, 2020 | 189.17B | 44.48% |
| Dec 31, 2019 | 130.93B | -5.58% |
| Dec 31, 2018 | 138.67B | -10.18% |
| Dec 29, 2017 | 154.39B | 51.71% |
| Dec 30, 2016 | 101.76B | 5.08% |
| Dec 31, 2015 | 96.84B | -7.12% |
| Dec 31, 2014 | 104.26B | 24.10% |
| Dec 31, 2013 | 84.01B | 51.40% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 884.72B |
| Johnson & Johnson | 579.34B |
| Novartis AG | 302.19B |
| AstraZeneca | 301.13B |
| Merck & Co. | 286.28B |
| Amgen | 199.20B |
| Gilead Sciences | 178.68B |
| Novo Nordisk | 171.00B |